BioCentury
ARTICLE | Product Development

China faces clinical delays during coronavirus outbreak

February 4, 2020 8:53 PM UTC
Updated on Mar 26, 2020 at 1:11 AM UTC

As China responds to the 2019-nCoV virus outbreak, executives of Chinese life sciences companies have pointed out that efforts to fight the virus could affect clinical trials across the nation, including postponement of new trials and continued enrollment of ongoing trials and increased usage of remote monitoring.

Dan Zhang, executive chairman of CRO Fountain Medical Development Ltd., told BioCentury that many clinical trials may be delayed, particularly in the Wuhan region because people cannot get into or out of the city. He added that other regions also face problems with clinical work. ...

BCIQ Company Profiles

ClinChoice Inc.